Luis
Bujanda Fernández de Piérola
Instituto de Investigación Sanitaria Valdecilla
Santander, EspañaPublications en collaboration avec des chercheurs de Instituto de Investigación Sanitaria Valdecilla (3)
2022
-
Novel genes and sex differences in COVID-19 severity
Human molecular genetics, Vol. 31, Núm. 22, pp. 3789-3806
2020
-
Effectiveness and Safety of the Sequential Use of a Second and Third Anti-TNF Agent in Patients with Inflammatory Bowel Disease: Results from the Eneida Registry
Inflammatory Bowel Diseases, Vol. 26, Núm. 4, pp. 606-616